157 related articles for article (PubMed ID: 38163190)
1. Expression and prognosis analysis of integrin subunit α3 (ITGA3) in papillary thyroid cancer.
Ma JJ; Xiang C; Zhu HQ; Bai BL; Wang P; Zhao GA
Heliyon; 2024 Jan; 10(1):e23163. PubMed ID: 38163190
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-524-5p suppresses the progression of papillary thyroid carcinoma cells via targeting on FOXE1 and ITGA3 in cell autophagy and cycling pathways.
Liu H; Chen X; Lin T; Chen X; Yan J; Jiang S
J Cell Physiol; 2019 Aug; 234(10):18382-18391. PubMed ID: 30941771
[TBL] [Abstract][Full Text] [Related]
3. Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer.
Koshizuka K; Hanazawa T; Kikkawa N; Arai T; Okato A; Kurozumi A; Kato M; Katada K; Okamoto Y; Seki N
Cancer Sci; 2017 Aug; 108(8):1681-1692. PubMed ID: 28612520
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of ITGA3 as a Biomarker of Progression and Recurrence in Papillary Thyroid Carcinoma.
Zhang G; Li B; Lin Y
Front Oncol; 2021; 11():614955. PubMed ID: 35174063
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-124-3p suppresses cell migration and invasion by targeting ITGA3 signaling in bladder cancer.
Wang JR; Liu B; Zhou L; Huang YX
Cancer Biomark; 2019; 24(2):159-172. PubMed ID: 30614803
[TBL] [Abstract][Full Text] [Related]
6. Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.
Sakaguchi T; Yoshino H; Yonemori M; Miyamoto K; Sugita S; Matsushita R; Itesako T; Tatarano S; Nakagawa M; Enokida H
Br J Cancer; 2017 Apr; 116(8):1077-1087. PubMed ID: 28324890
[TBL] [Abstract][Full Text] [Related]
7. High integrin α3 expression is associated with poor prognosis in patients with non-small cell lung cancer.
Li Q; Ma W; Chen S; Tian EC; Wei S; Fan RR; Wang T; Zhou C; Li T
Transl Lung Cancer Res; 2020 Aug; 9(4):1361-1378. PubMed ID: 32953510
[TBL] [Abstract][Full Text] [Related]
8. Identifying the prognosis implication, immunotherapy response prediction value, and potential targeted compound inhibitors of integrin subunit α3 (ITGA3) in human cancers.
Gui J; Yang L; Liu J; Li Y; Zou M; Sun C; Huang L; Zhu X; Huang K
Heliyon; 2024 Jan; 10(2):e24236. PubMed ID: 38293430
[TBL] [Abstract][Full Text] [Related]
9. Evaluate the diagnostic and prognostic value of NUSAP1 in papillary thyroid carcinoma and identify the relationship with genes, proteins, and immune factors.
Gao T; Zhao L; Zhang F; Cao C; Fan S; Shi X
World J Surg Oncol; 2022 Jun; 20(1):207. PubMed ID: 35710427
[TBL] [Abstract][Full Text] [Related]
10. A Novel Necroptosis-Related miRNA Signature for Predicting the Prognosis of Breast Cancer Metastasis.
Zheng L; Wang J; Jiang H; Dong H
Dis Markers; 2022; 2022():3391878. PubMed ID: 35371342
[TBL] [Abstract][Full Text] [Related]
11. Reveal the potential molecular mechanism of circRNA regulating immune-related mRNA through sponge miRNA in the occurrence and immune regulation of papillary thyroid cancer.
Wang B; Shen W; Yan L; Li X; Zhang L; Zhao S; Jin X
Ann Med; 2023; 55(2):2244515. PubMed ID: 37603701
[TBL] [Abstract][Full Text] [Related]
12.
Jiao Y; Li Y; Liu S; Chen Q; Liu Y
Onco Targets Ther; 2019; 12():4141-4152. PubMed ID: 31213833
[No Abstract] [Full Text] [Related]
13.
Li Y; Li F; Bai X; Li Y; Ni C; Zhao X; Zhang D
Front Oncol; 2021; 11():658547. PubMed ID: 34094951
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA‑199a‑5p suppresses cell proliferation, migration and invasion by targeting ITGA3 in colorectal cancer.
Tian L; Chen M; He Q; Yan Q; Zhai C
Mol Med Rep; 2020 Sep; 22(3):2307-2317. PubMed ID: 32705201
[TBL] [Abstract][Full Text] [Related]
15. Expression profiles of microRNAs and their target genes in papillary thyroid carcinoma.
Liu X; He M; Hou Y; Liang B; Zhao L; Ma S; Yu Y; Liu X
Oncol Rep; 2013 Apr; 29(4):1415-20. PubMed ID: 23380809
[TBL] [Abstract][Full Text] [Related]
16. ITGA3 and ITGB4 expression biomarkers estimate the risks of locoregional and hematogenous dissemination of oral squamous cell carcinoma.
Nagata M; Noman AA; Suzuki K; Kurita H; Ohnishi M; Ohyama T; Kitamura N; Kobayashi T; Uematsu K; Takahashi K; Kodama N; Kawase T; Hoshina H; Ikeda N; Shingaki S; Takagi R
BMC Cancer; 2013 Sep; 13():410. PubMed ID: 24006899
[TBL] [Abstract][Full Text] [Related]
17. Involvement of anti-tumor
Idichi T; Seki N; Kurahara H; Fukuhisa H; Toda H; Shimonosono M; Yamada Y; Arai T; Kita Y; Kijima Y; Mataki Y; Maemura K; Natsugoe S
Oncotarget; 2018 Jun; 9(48):28849-28865. PubMed ID: 29988949
[TBL] [Abstract][Full Text] [Related]
18. Integrated bioinformatics analysis shows integrin alpha 3 is a prognostic biomarker for pancreatic cancer.
Hu F; Zhao L; Wang Y; Ye H; Tang H; Zhou J
Open Med (Wars); 2022; 17(1):1935-1943. PubMed ID: 36561844
[TBL] [Abstract][Full Text] [Related]
19. Exosomal hsa-miR-129-2 and hsa-miR-889 from a 6-microRNA Signature Might be a Potential Biomarker for Predicting the Prognosis of Papillary Thyroid Carcinoma.
Xin Y; Meng K; Guo H; Chen B; Zheng C; Shou X; Yu K
Comb Chem High Throughput Screen; 2022; 25(5):819-830. PubMed ID: 33550967
[TBL] [Abstract][Full Text] [Related]
20. Identification of key miRNAs in papillary thyroid carcinoma based on data mining and bioinformatics methods.
Wang J; Wu L; Jin Y; Li S; Liu X
Biomed Rep; 2020 Jan; 12(1):11-16. PubMed ID: 31839944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
